Due to the aberrant splicing of LZTR1 (leucine zipper-like transcriptional regulator 1), mutations in the splicing factor ZRSR2 have been associated with a number of illnesses, including myelodysplastic syndromes (MDS) and predispositions to cancer [65]. Here, ZRSR2 is linked to myelodysplastic syndrome.